摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-methylpiperazine-1-carbonyl)-2-(trifluoromethyl)naphtho[2,3-b]furan-4,9-dione

中文名称
——
中文别名
——
英文名称
3-(4-methylpiperazine-1-carbonyl)-2-(trifluoromethyl)naphtho[2,3-b]furan-4,9-dione
英文别名
3-(4-Methylpiperazine-1-carbonyl)-2-(trifluoromethyl)benzo[f][1]benzofuran-4,9-dione;3-(4-methylpiperazine-1-carbonyl)-2-(trifluoromethyl)benzo[f][1]benzofuran-4,9-dione
3-(4-methylpiperazine-1-carbonyl)-2-(trifluoromethyl)naphtho[2,3-b]furan-4,9-dione化学式
CAS
——
化学式
C19H15F3N2O4
mdl
——
分子量
392.334
InChiKey
ITSDPFSFOYXRQD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    28
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    70.8
  • 氢给体数:
    0
  • 氢受体数:
    8

文献信息

  • [EN] 3-SUBSTITUTED CARBONYL-NAPHTHO[2,3-B]FURANE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF<br/>[FR] DÉRIVÉ DE CARBONYLE -NAPHTO [2,3-B]FURANE 3-SUBSTITUÉ DÉRIVÉ OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI
    申请人:BOSTON BIOMEDICAL INC
    公开号:WO2015120304A1
    公开(公告)日:2015-08-13
    The present invention provides a compound of the following Formula (1) or a pharmaceutically acceptable salt thereof: Formule (i) wherein X is an oxygen atom and the like; Y is -CO-, -S02-and the like; R1 is an optionally- substituted C1-6 alkyl group, an optionally-substituted C1-6 alkylcarbonyl group and the like; R2 is an optionally- substituted C1-6 alkyl group, an optionally-substituted C1-6 alkoxy group, an optionally-substituted amino group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic saturated heterocyclic group and the like; R3, R4, R5, and R6 are independently a hydrogen atom and the like which exhibits excellent effects in suppressing the proliferation and sphere-forming ability of cancer cells, and can be useful as an antitumor drug or cell growth inhibitor.
    本发明提供以下式(1)的化合物或其药学上可接受的盐:式(i)其中X是氧原子等;Y是-CO-,-S02-等;R1是可选择地取代的C1-6烷基,可选择地取代的C1-6烷基羰基等;R2是可选择地取代的C1-6烷基,可选择地取代的C1-6烷氧基,可选择地取代的氨基,可选择地取代的5-至12-成员的单环或多环饱和杂环基等;R3、R4、R5和R6独立地是氢原子等,对抑制癌细胞的增殖和球形形成能力具有出色效果,并可用作抗肿瘤药物或细胞生长抑制剂。
  • 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
    申请人:Boston Biomedical, Inc.
    公开号:US10017488B2
    公开(公告)日:2018-07-10
    The present invention provides a compound of the following Formula (1) or a pharmaceutically acceptable salt thereof: wherein X is an oxygen atom and the like; Y is —CO—, —SO2— and the like; R1 is an optionally-substituted C1-6 alkyl group, an optionally-substituted C1-6 alkylcarbonyl group and the like; R2 is an optionally-substituted C1-6 alkyl group, an optionally-substituted C1-6 alkoxy group, an optionally-substituted amino group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic saturated heterocyclic group and the like; R3, R4, R5, and R6 are independently a hydrogen atom and the like which exhibits excellent effects in suppressing the proliferation and sphere-forming ability of cancer cells, and can be useful as an antitumor drug or cell growth inhibitor.
    本发明提供了下式(1)的化合物或其药学上可接受的盐: 其中 X 是氧原子等;Y 是 -CO-、-SO2- 等;R1 是任选取代的 C1-6 烷基、任选取代的 C1-6 烷基羰基等;R2 是任选取代的 C1-6 烷基、任选取代的 C1-6 烷氧基、任选取代的氨基、任选取代的 5 至 12 元单环或多环饱和杂环基等;R3、R4、R5 和 R6 独立地为氢原子等,在抑制癌细胞增殖和癌细胞球形成能力方面具有优异的效果,可用作抗肿瘤药物或细胞生长抑制剂。
  • Heterocycle-substituted bicyclic azole pesticides
    申请人:FMC CORPORATION
    公开号:US10150782B2
    公开(公告)日:2018-12-11
    Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein Q is and A, R1, m, X1, X2, X3, X4, Y1, Y2 and Y3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
    公开的是式 1 的化合物,包括所有几何异构体和立体异构体、N-氧化物及其盐类、 其中 Q 是 和 A、R1、m、X1、X2、X3、X4、Y1、Y2 和 Y3 如公开内容中所定义。还公开了含有式 1 化合物的组合物和控制无脊椎害虫的方法,该方法包括将生物有效量的本发明化合物或组合物与无脊椎害虫或其环境接触。
  • 3-SUBSTITUTED CARBONYL-NAPHTHO[2,3-B]FURANE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    申请人:Boston Biomedical, Inc.
    公开号:US20170174646A1
    公开(公告)日:2017-06-22
    The present invention provides a compound of the following Formula (1) or a pharmaceutically acceptable salt thereof: wherein X is an oxygen atom and the like; Y is —CO—, —SO 2 — and the like; R 1 is an optionally-substituted C 1-6 alkyl group, an optionally-substituted C 1-6 alkylcarbonyl group and the like; R 2 is an optionally-substituted C 1-6 alkyl group, an optionally-substituted C 1-6 alkoxy group, an optionally-substituted amino group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic saturated heterocyclic group and the like; R 3 , R 4 , R 5 , and R 6 are independently a hydrogen atom and the like which exhibits excellent effects in suppressing the proliferation and sphere-forming ability of cancer cells, and can be useful as an antitumor drug or cell growth inhibitor.
  • HETEROCYCLE-SUBSTITUTED BICYCLIC AZOLE PESTICIDES
    申请人:E I DU PONT DE NEMOURS AND COMPANY
    公开号:US20170174707A1
    公开(公告)日:2017-06-22
    Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein Q is and A, R 1 , m, X 1 , X 2 , X 3 , X 4 , Y 1 , Y 2 and Y 3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
查看更多

同类化合物

黄药子素C 黄独素A 香紫苏内酯 降龙涎香醚 阿霉素(α-β混合物) 银线草内酯醇 辛辣木素 载脂蛋白-土霉素 萘并[2,3-c]呋喃-3(1H)-酮 萘并[2,3-c]呋喃-1,3-二酮,5,8-二甲基-(9CI) 萘并[2,3-c]呋喃-1(3H)-酮,4-(3-呋喃基)-7-羟基- 萘并[2,3-b]呋喃-4,9-二酮,2,3-二氢-2-甲基-2-苯基- 萘并[2,1-b]呋喃-2-甲酰肼 萘并[2,1-b]呋喃-2(1H)-酮 萘并[2,1-b]呋喃-1-乙酸 萘并[1,2-b]呋喃-2-醇,2,3,3a,4,5,5a,6,7,9a,9b-十氢-3,5a,9-三甲基- 萘并[1,2-b]呋喃-2(3H)-酮,3a,4,5,9b-四氢-8-羟基-3,9-二甲基-,(3R,3aR,9bS)-rel- 萘并(2,3-b)呋喃-4,9-二酮 萘[2,1-b]呋喃-2-羧酸乙酯 荧蒽-2,3-二甲酸酐 苯并[g][1]苯并呋喃-8,9-二酮 苯并[g][1]苯并呋喃-3-酮 苯并[g][1]苯并呋喃-2-甲醛 苯并[g][1]苯并呋喃 苯并[f][1]苯并呋喃-3-酮 苯并[e][1]苯并呋喃-8-醇 苯并[e][1]苯并呋喃-1-酮 苯并[e][1]苯并呋喃 苯并[b]萘并[2,3-d]呋喃 苯并[b]萘并[2,1-d]呋喃 苯并[b]萘并[1,2-d]呋喃 苯并[B]萘并[2,3-D]呋喃-2-羟基硼酸 苯基(6,7,8,9-四氢萘并[2,1-b]呋喃-2-基)甲醇 苊并[5,4-b]呋喃-4,5-二酮,7,8-二氢-3,6-二羟基-1,7,7,8-四甲基-,(8S)- 维生素K1相关化合物 红葱酚 白术内酯 I 珀勒内B 珀勒内A 沃拉帕沙杂质 沃拉帕沙 沃拉帕沙 沃拉帕沙 己二酸,聚合2,2-二(羟甲基)-1,3-丙二醇,1,3-异苯并呋喃二酮和2,2-氧代二乙醇,2-丙烯酸酯 岩大戟内酯B 岩大戟内酯A 密叶辛木素 咖啡醇 咖啡豆醇乙酸酯 咖啡豆醇